Regulation of xenogeneic porcine pancreatic islets (original) (raw)

Xenotransplantation, 2010

Abstract

The use of xenogeneic porcine pancreatic islets has been shown to be a potentially promising alternative to using human allogeneic islets to treat insulin-dependent type 1 diabetes (T1D). This article provides an overview of the existing FDA regulatory framework that would be applied to the regulation of clinical trials utilizing xenogeneic porcine pancreatic islets to treat T1D.

Larisa Rudenko hasn't uploaded this paper.

Let Larisa know you want this paper to be uploaded.

Ask for this paper to be uploaded.